Eiger BioPharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Eiger BioPharmaceuticals, Inc.
CIK #0001305253, 0001454815
EDGAR Form CIK 2011 - 2025
10-K [0001305253]
10-Q [0001305253]
3 [0001305253]
4 [0001305253]
8-K [0001305253]
D [0001305253]
SC 13D [0001305253]
SC 13G [0001305253]
D [0001454815]
SC 13G [0001454815]
Form 13D/13G Filer Form 13D/13G Subject Filed
Arkin Moshe Eiger Biopharmaceuticals Inc [2024-08-26]
Arkin Moshe Eiger Biopharmaceuticals Inc [2023-11-24]
Propel Bio Management LLC Eiger Biopharmaceuticals Inc [2023-10-20]
Propel Bio Management LLC Eiger Biopharmaceuticals Inc [2023-08-15]
Adage Capital Partners GP LLC Eiger Biopharmaceuticals Inc [2022-05-02]
Arkin Moshe Eiger Biopharmaceuticals Inc [2022-03-08]
Ameriprise Financial Inc Eiger Biopharmaceuticals Inc [2022-01-21]
Ameriprise Financial Inc Eiger Biopharmaceuticals Inc [2021-01-11]
BlackRock Inc Eiger Biopharmaceuticals Inc [2020-02-07]
Broadfin Capital LLC Eiger Biopharmaceuticals Inc [2019-06-14]
View All
Form 3/4/5 Subject 2011 - 2025
Eiger BioPharmaceuticals, Inc.
Kayne Richard A
Kawas LEEN
Choong Ingrid
Apelian David
Vollins James
Kachioff William G
Mayer Eldon C. III
Kelly-Croswell Lisa
Glenn Jeffrey S
View All
Terms | Privacy | Guide
tony@aum13f.com